Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 8x8 Inc (EGHT) vs Nuwellis Inc (NUWE) Price & Performance

Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

8x8 Inc vs Nuwellis Inc — how do they compare? 8x8 Inc trades at $2 (market cap $309.09M), while Nuwellis Inc trades at $1.42 (market cap $542.80K). The key difference: 8x8 Inc is far larger — about 569.4× Nuwellis Inc's market cap, and 8x8 Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

EGHTNUWE
Market Cap
$309.09M$542.80K
Sector
TechnologyTechnology
52-Week High
$2.76$220.50
52-Week Low
$1.59$1.42
Enterprise Value
$576.02M-$1.27M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

8x8 Inc

EGHT trades at $2.06, down 8.04% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with five consecutive quarters of revenue growth and consistent earnings beats, though profitability remains thin with a 0.64% net margin. Recent AI product expansions and partner program launches signal strategic growth initiatives. Analyst consensus targets $3.13, representing 52% upside potential from current levels.

EGHT presents a compelling risk-reward profile with significant analyst upside but faces execution risks in a competitive communications sector. The transition to profitability in 2026 forecasts and strong institutional support offset near-term volatility concerns. Key risks include high debt levels and margin pressure, while AI adoption growth and consistent earnings outperformance provide catalysts for valuation expansion.

Nuwellis Inc

NUWE trades at $1.43, up 0.7% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of -$17.52M in 2025, with a negative net income margin of -217.22%, though recent news highlights product development and revenue growth initiatives, including a 14% preliminary year-over-year revenue increase in Q2 2026.

Outlook is cautious due to persistent losses and high cash burn, but growth in pediatric installations and strategic expansions offer potential. Risks include financial sustainability and competitive pressures, while analyst coverage is limited with a split buy/hold consensus.

Returns comparison

Trailing returns across standard periods

About 8x8 Inc

8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.

Read more on EGHT

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE